Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib

Objective To assess the efficacy and tolerability of rechallenge with sunitinib and other targeted therapies (TTs) in patitents with relapsed recurrent renal cell carcinoma (RCC) in the advanced setting. Methods In this multi‐institutional retrospective study, patients with relapsed RCC were rechallenged with sunitinib or other systemic TTs as a first‐line therapeutic approach after failed adjuvant sunitinib treatment. Patient characteristics,...